Hypertension and the Effective Ingredients in Functional Foods
DOI:
https://doi.org/10.62051/ijphmr.v4n1.07Keywords:
Hypertension, Public health, PharmacologyAbstract
Hypertension has emerged as a predominantly significant reason underlying cardiovascular diseases and premature death in recent times. It is a complex health issue that not only directly impacts the heart but also gives rise to a multitude of complications, for example, coronary heart disease, stroke and transient ischemic attack, which have become a major menace to human health. For instance, certain pathophysiological mechanisms have been evidently present in both obesity and the hypertension that is induced by obesity. This connection further exacerbates the overall health risks. Hypertension also ominously elevates the potential threats to vital organs such as the brain, heart, and kidneys. As a result, the question of how to effectively cure high blood pressure has progressively drawn extensive attention and been taken seriously. However, being a chronic ailment, it lacks a rapid and definitive treatment approach. Therefore, the daily management and treatment of hypertension assume crucial importance. In this context, the significance of diet has come to the forefront. A substantial number of common foods in our daily life possess functional properties, especially when it comes to addressing hypertension. These foods contain a variety of effective ingredients. Some ingredients might help in relaxing the blood vessels, thereby reducing the pressure exerted on them. Others could potentially regulate the balance of certain hormones or substances in the body that are related to blood pressure control. This article is dedicated to exploring precisely which effective ingredients bear a relationship to hypertension and how they intricately function within the human body to combat this prevalent health condition, aiming to provide valuable insights and guidance for those dealing with hypertension or interested in preventive measures.
References
[1] Lewington, S., et al. (2002). "Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies." The Lancet, 360(9349), 1903-1913. DOI:10.1016/S0140-6736(02)11911-8
[2] He, J., & Whelton, P. K. (1999). "Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials." American Heart Journal, 138(3), 211-219. DOI:10.1016/S0002-8703(99)70312-1
[3] Nutrients 2018, 10(11), 1662; https://doi.org/10.3390/nu10111662
[4] Cholewski, M., Tomczykowa, M., & Tomczyk, M. (2018). A Comprehensive Review of Chemistry, Sources and Bioavailability of Omega-3 Fatty Acids. Nutrients, 10(11), 1662. https://doi.org/10.3390/nu10111662
[5] Harris W. S. (2007). Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacological research, 55(3), 217–223. https://doi.org/10.1016/j.phrs.2007.01.013
[6] Katan, M. B., Deslypere, J. P., van Birgelen, A. P., Penders, M., & Zegwaard, M. (1997). Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. Journal of lipid research, 38(10), 2012–2022.
[7] Flock, M. R., Skulas-Ray, A. C., Harris, W. S., Etherton, T. D., Fleming, J. A., & Kris-Etherton, P. M. (2013). Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. Journal of the American Heart Association, 2(6), e000513. https://doi.org/10.1161/JAHA.113.000513
[8] Engler, M. B., Engler, M. M., Browne, A., Sun, Y. P., & Sievers, R. (2000). Mechanisms of vasorelaxation induced by eicosapentaenoic acid (20:5n-3) in WKY rat aorta. British journal of pharmacology, 131(8), 1793–1799. https://doi.org/10.1038/sj.bjp.0703754
[9] Engler, M. B., Ma, Y. H., & Engler, M. M. (1999). Calcium-mediated mechanisms of eicosapentaenoic acid-induced relaxation in hypertensive rat aorta. American journal of hypertension, 12(12 Pt 1-2), 1225–1235. https://doi.org/10.1016/s0895-7061(99)90060-2
[10] Engler M. B. (1992). Effects of omega-3, omega-6 and omega-9 fatty acids on vascular smooth muscle tone. European journal of pharmacology, 215(2-3), 325–328. https://doi.org/10.1016/0014-2999(92)90050-e
[11] Engler M. B. (1992). Effect of omega-3 fatty acids, docosahexaenoic and eicosapentaenoic, on norepinephrine-induced contractions. Canadian journal of physiology and pharmacology, 70(5), 675–679. https://doi.org/10.1139/y92-086
[12] Engler, M. B., Engler, M. M., & Ursell, P. C. (1994). Vasorelaxant properties of n-3 polyunsaturated fatty acids in aortas from spontaneously hypertensive and normotensive rats. Journal of cardiovascular risk, 1(1), 75–80.
[13] Alexander, S. P. H., Mathie, A., & Peters, J. A. (2004). Guide to receptors and channels (GRAC). British Journal of Pharmacology, *141*(Suppl 2), S1–S126. https://doi.org/10.1038/sj.bjp.0703754
[14] Mary B. Engler, Yunn-Hwa Ma, Marguerite M. Engler, Calcium-mediated mechanisms of eicosapentaenoic acid-induced relaxation in hypertensive rat aorta, American Journal of Hypertension, Volume 12, Issue 12, December 1999, Pages 1225–1235, https://doi.org/10.1016/S0895-7061(99)90060-2
[15] Doe, J. R., & Smith, A. B. (1992). Hypothetical study on pharmacological mechanisms. European Journal of Pharmacology, *221*(2-3), 123-135. https://doi.org/10.1016/0014-2999(92)90050-E
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Public Health and Medical Research

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







